A continuación se publica una selección de tuits recientes de @sanoysalvoblog
1/4 of trial exclude old patients! MT“@sanoysalvoblog: BMJ - Clinical research must include older people http://t.co/GyCosXIPEd #PtSafety”
— Ram Fernando (@RamFernando1) June 22, 2013
(BMJ) Restructuring health systems for an era of prolonged austerity: an essay by Richard B Saltman and Zachary Cahn http://t.co/LojmSuR3uU
— Sano y salvo (@sanoysalvoblog) June 24, 2013
The science of human factors in patient safety: here's an article that distinguishes fact from fiction. Open access.http://t.co/RM7LlWshlT
— BMJ Quality & Safety (@BMJ_Qual_Saf) June 23, 2013
(UKMi) Is there a suitable vitamin D product for a patient with a peanut or soya allergy? http://t.co/NeljS80GM0 #PtSafety #AdverseEffects
— Sano y salvo (@sanoysalvoblog) June 24, 2013
What is the clinical significance of potential drug interactions with anaesthetic preparations used in dentistry? http://t.co/l7PF8tE8WS
— Sano y salvo (@sanoysalvoblog) June 24, 2013
Pese a las especificaciones de CONSORT la información sobre EAs en los ECAs sigue siendo pobre... #SegPac
— X.M. Meijome (@EnferEvidente) June 24, 2013
(CIMUM COL) La EMA emite seis estrategias para abordar los errores de medicación http://t.co/N3v7DUBp3z) #SegPac
— Sano y salvo (@sanoysalvoblog) June 25, 2013
(BMJ Letter) Statins are not bad medicine but their misuse is http://t.co/DQyktViZNH #PtSafety
— Sano y salvo (@sanoysalvoblog) June 25, 2013
(BMJ) Excess mortality associated with diabetes is falling, study shows http://t.co/sOAPbQMTyl #PtSafety
— Sano y salvo (@sanoysalvoblog) June 25, 2013
Calcitonina: intervención para mejorar la seguridad del paciente y la eficiencia de la prescripción http://t.co/AjWAOujov2 #SegPac
— Sano y salvo (@sanoysalvoblog) June 26, 2013
Strategies to prevent medication errors and adverse drug events. #AHRQ Patient Safety Primers: http://t.co/OProVp5UTE #PtSafety
— Sano y salvo (@sanoysalvoblog) June 26, 2013
(BMJ) EMA consults public on plan to increase transparency of drug trial data http://t.co/tv2r8RGCWO #AllTrials #PtSafety
— Sano y salvo (@sanoysalvoblog) June 26, 2013
ADA/EASD Recommendations Concerning the Use of Incretin Therapy and Pancreatic Disease http://t.co/s2mDgp8kod #PtSafety
— Sano y salvo (@sanoysalvoblog) June 27, 2013
La deprescripción como herramienta para el uso seguro del medicamento (vídeo) http://t.co/vKuuZsQuul por @enriquegavilan #SegPac
— Sano y salvo (@sanoysalvoblog) June 27, 2013
More sleep urged for residency doctors by @david_andreatta http://t.co/TddlwsCq00 via @globeandmail #cdnhealth #ptsafety #meded
— André Picard (@picardonhealth) June 27, 2013
(EMA) New restrictions on use of medicines containing ergot derivatives http://t.co/acgtJ0cV5l #PtSafety
— Sano y salvo (@sanoysalvoblog) June 28, 2013
CMDh has endorsed PRAC recommendation on restrictions on use of #codeine for pain relief in children: http://t.co/lLAnnWuENi
— EMA (@EMA_News) June 28, 2013
This morning we issued recommendations to manage risk of allergic reactions with IV #iron-containing medicines: http://t.co/g8Vnw4jUKB
— EMA (@EMA_News) June 28, 2013
CMDh has endorsed PRAC recommendation on new safety advice for #diclofenac to minimise cardiovascular risks: http://t.co/lppIobjNuB
— EMA (@EMA_News) June 28, 2013
(MHRA) Oral retinoids: pregnancy prevention—reminder of measures to minimise teratogenic risk http://t.co/sUFIy9Wjud #PtSafety
— Sano y salvo (@sanoysalvoblog) June 28, 2013
Grupo de defensa de la ISDB o cómo aprender a hacer lobby http://t.co/9rohOoOtsr #AllTrials #NoGracias #SegPac
— Sano y salvo (@sanoysalvoblog) June 28, 2013
US Study Shows Increased Rate of Liver Injury Due to Prescription and OTC Drugs http://t.co/858Oc8cNfx #PtSafety
— Sano y salvo (@sanoysalvoblog) June 28, 2013
(AAFP) Reducing the Risk of Adverse Drug Events in Older Adults https://t.co/c49FgVL8OG vía @velezmeca #PtSafety
— Sano y salvo (@sanoysalvoblog) June 28, 2013
Manejo de la intolerancia a estatinas, por RxFiles http://t.co/MpewmOkXr2 vía @JesusmRedondo #SegPac
— Sano y salvo (@sanoysalvoblog) June 29, 2013
Soluciones para perfusión que contienen hidroxietil-almidón: revisión del balance beneficio-riesgo http://t.co/OnJtEhb0bT
— AEMPS (@AEMPSGOB) June 18, 2013
RT @Olguitxi Suspension definitiva de Hidroxietilalmidon 6% en UK https://t.co/sZyg8ytAZz #SegPac #UrgenciasAP
— Sano y salvo (@sanoysalvoblog) June 29, 2013
Ese terrible momento en el que te das cuenta de que has cometido un error de dispensación http://t.co/smWr5iR0Fb vía @Mavegare #SegPac
— Sano y salvo (@sanoysalvoblog) June 29, 2013
RT @Mavegare Canadá ("error de empaquetado"): 14 comprimidos de placebo en un anticonceptivo en lugar de 7: http://t.co/WO8x2ie31x #SegPac
— Sano y salvo (@sanoysalvoblog) June 29, 2013
Publicado por Sano y salvo
0 comentarios:
Publicar un comentario